Enhanced metabolism and negative regulation of ER stress support higher erythropoietin production in HEK293 cells.
ATF6B
CP: Cell biology
CP: Molecular biology
Cell engineering
GFP
HEK293
erythropoietin
protein production
ribosome heterogeneity
secretory pathways
Journal
Cell reports
ISSN: 2211-1247
Titre abrégé: Cell Rep
Pays: United States
ID NLM: 101573691
Informations de publication
Date de publication:
14 06 2022
14 06 2022
Historique:
received:
28
09
2020
revised:
05
01
2022
accepted:
18
05
2022
entrez:
15
6
2022
pubmed:
16
6
2022
medline:
18
6
2022
Statut:
ppublish
Résumé
Recombinant protein production can cause severe stress on cellular metabolism, resulting in limited titer and product quality. To investigate cellular and metabolic characteristics associated with these limitations, we compare HEK293 clones producing either erythropoietin (EPO) (secretory) or GFP (non-secretory) protein at different rates. Transcriptomic and functional analyses indicate significantly higher metabolism and oxidative phosphorylation in EPO producers compared with parental and GFP cells. In addition, ribosomal genes exhibit specific expression patterns depending on the recombinant protein and the production rate. In a clone displaying a dramatically increased EPO secretion, we detect higher gene expression related to negative regulation of endoplasmic reticulum (ER) stress, including upregulation of ATF6B, which aids EPO production in a subset of clones by overexpression or small interfering RNA (siRNA) knockdown. Our results offer potential target pathways and genes for further development of the secretory power in mammalian cell factories.
Identifiants
pubmed: 35705050
pii: S2211-1247(22)00718-5
doi: 10.1016/j.celrep.2022.110936
pii:
doi:
Substances chimiques
Recombinant Proteins
0
Erythropoietin
11096-26-7
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
110936Informations de copyright
Copyright © 2022 The Authors. Published by Elsevier Inc. All rights reserved.
Déclaration de conflit d'intérêts
Declaration of interests P.-O.B. is cofounder and CEO of Biocrine AB. L.G. and D.H. are employees of AstraZeneca and may own AstraZeneca stock or stock options.